Household Healthcare Sector

Sentient Brands Holdings

Market Cap: US$6.0m

A product development and brand management company, builds brands in the luxury and premium market space.

GENinCode

Market Cap: UK£4.4m

Develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient’s health based on their genes in the United Kingdom and internationally.

American Films

Market Cap: US$6.0m

Does not have significant operations.

Soligenix

Market Cap: US$6.0m

A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.

Control Bionics

Market Cap: AU$9.1m

Engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally.

Unified Global

Market Cap: US$5.9m

Operates as a vertically integrated cannabis company in Canada and the United States.

Biofrontera

Market Cap: US$5.9m

A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Channel Therapeutics

Market Cap: US$5.8m

A clinical-stage biotech company, develops and commercializes new therapeutics to alleviate pain.

Bionoid Pharma

Market Cap: US$5.8m

Engages in the hemp cultivation business.

Mobile-health Network Solutions

Market Cap: US$5.8m

An investment holding company, provides telehealth solutions primarily in Singapore.

Eyenovia

Market Cap: US$5.7m

An ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States.

Jaguar Health

Market Cap: US$5.7m

A commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress.

Pasithea Therapeutics

Market Cap: US$5.7m

A clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers.

Sigyn Therapeutics

Market Cap: US$5.7m

A development-stage company, provides therapeutic solutions to treat cancer and infectious disease disorders in the United States.

HealthLynked

Market Cap: US$5.6m

A healthcare technology company, operates a cloud-based patient information network and record archiving system in the United States.

Incannex Healthcare

Market Cap: US$5.6m

A clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia.

Sproutly Canada

Market Cap: CA$7.6m

Produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumables markets in Canada.

Intensity Therapeutics

Market Cap: US$5.5m

A late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States.

Cannabis Bioscience International Holdings

Market Cap: US$5.5m

Cannabis Bioscience International Holdings, Inc.

BioElectronics

Market Cap: US$5.4m

An electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide.

BioCorRx

Market Cap: US$5.4m

Through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States.

Argent BioPharma

Market Cap: AU$8.3m

A multidisciplinary drug development Company, engages in the provision of medicines targeting immunology and neurology worldwide.

Klotho Neurosciences

Market Cap: US$5.4m

Develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders.

DATATRAK International

Market Cap: US$5.4m

A technology and services company, provides unified clinical solutions and related services for the clinical trials industry.

Sonoma Pharmaceuticals

Market Cap: US$5.4m

Develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye and nasal care, oral care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.

180 Life Sciences

Market Cap: US$5.4m

A clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States.

StateHouse Holdings

Market Cap: CA$7.7m

An integrated omni-channel cannabis company, engages in the cultivation, processing, manufacture, distribution, and retailing of cannabis products for the adult-use and medical markets in the United States.

FutureNet

Market Cap: US$5.4m

This record represents the public shell of FutureNet Inc.

N4 Pharma

Market Cap: UK£4.0m

A specialist pharmaceutical company, develops silica nanoparticle delivery systems to enhance the cellular delivery of cancer treatments, gene therapy, and vaccines in the United Kingdom.

NutraProducts

Market Cap: US$5.3m

A contract manufacturer, engages in the production of gummy supplements.

Plus Therapeutics

Market Cap: US$5.3m

A clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.

AppYea

Market Cap: US$5.3m

A digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring.

Dogecoin Cash

Market Cap: US$5.2m

Through its subsidiaries, provides telemedicine online referral services for customers desiring medical marijuana cards in the United States.

Innovative Holdings Alliance

Market Cap: US$5.2m

A medical technology holding company, offers personal care products in North America.

HITIQ

Market Cap: AU$8.0m

Engages in development and commercialization of concussion management technology and software in Australia.

Kovo+ Holdings

Market Cap: CA$7.1m

Operates as a healthcare technology company.